Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Konstantinos Skobridis"'
Autor:
Louisa Pechlivani, Nikoleta Ntemou, Despoina Pantazi, Dimitrios Alivertis, Konstantinos Skobridis, Alexandros D. Tselepis
Publikováno v:
Pharmaceuticals, Vol 17, Iss 3, p 349 (2024)
Nilotinib, a second-generation tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia (CML), inhibits Bcr-Abl tyrosine kinase activity and proliferation of Bcr-Abl-expressing cells, as well as other malignancies. In the present s
Externí odkaz:
https://doaj.org/article/1851120662204c2997d6b10f53fb3daa
Autor:
Vassiliki Theodorou, Michalis Alagiannis, Nikoleta Ntemou, Alexios Brentas, Pinelopi Voulgari, Vasiliki Polychronidou, Marina Gogou, Marios Giannelos, Konstantinos Skobridis
Publikováno v:
ARKIVOC, Vol 2018, Iss 7, Pp 308-319 (2018)
Externí odkaz:
https://doaj.org/article/b22587ceb2b5459ebfde892527b3494d
Publikováno v:
ARKIVOC, Vol 2015, Iss 7, Pp 101-112 (2015)
Externí odkaz:
https://doaj.org/article/14be350787d949ebbe5ec13600507a49
Autor:
Katerina Arvaniti, Anastasia Papadioti, Maria Kinigopoulou, Vassiliki Theodorou, Konstantinos Skobridis, Georgios Tsiotis
Publikováno v:
Proteomes, Vol 2, Iss 3, Pp 363-381 (2014)
Imatinib mesylate is the leading compound to treat chronic myeloid leukemia (CML) and other cancers, through its inhibition of Bcr-Abl tyrosine kinases. However, resistance to imatinib develops frequently, particularly in late-stage disease and has n
Externí odkaz:
https://doaj.org/article/d25cd1a7f3f94383bc4e6658b157315e
Publikováno v:
ARKIVOC, Vol 2014, Iss 4, Pp 11-23 (2013)
Externí odkaz:
https://doaj.org/article/3239fa62f3894ca1b7b44a78ec6d158c
Publikováno v:
ARKIVOC, Vol 2006, Iss 10, Pp 102-106 (2006)
Externí odkaz:
https://doaj.org/article/cf44482a96944744b9851dd187da6f29
Publikováno v:
ARKIVOC, Vol 2005, Iss 6, Pp 459-469 (2005)
Externí odkaz:
https://doaj.org/article/dfe0551f505f44fab0dcc85c204b77fa
Autor:
Konstantinos Skobridis, Vassiliki Theodorou, Georgios Paraskevopoulos, Wilhelm Seichter, Edwin Weber
Publikováno v:
Acta Crystallographica Section E, Vol 69, Iss 10, Pp o1514-o1515 (2013)
The asymmetric unit of the title compound, C44H30O2, contains two independent molecules in which the terminal rings of the terphenyl element are inclined at angles of 36.3 (1) and 22.5 (1)° with respect to the central ring and the dihedral angles be
Externí odkaz:
https://doaj.org/article/034bd101a09949bb836a102cec2213b6
Autor:
Antonela Ananiadou, Michalis Alagiannis, Martin Steinhart, Konstantinos Skobridis, George Floudas
Publikováno v:
The Journal of Physical Chemistry C. 126:16409-16420
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2692d811fc2eac86ed73b0a91f93c092
https://doi.org/10.1021/acs.jpcc.2c04631
https://doi.org/10.1021/acs.jpcc.2c04631
Autor:
Anna Kosma, Despoina Pantazi, Pinelopi Voulgari, Nikoleta Ntemou, Alexios Brentas, Dimitrios Alivertis, Michael G. Siskos, Alexandros D. Tselepis, Konstantinos Skobridis
Publikováno v:
ChemistrySelect. 8
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::216bf8b623376a80e5c2c7f8277d909f
https://doi.org/10.1002/slct.202200405
https://doi.org/10.1002/slct.202200405